5 August 2014
a
Details
is developing complete process technologies
for the biobased production of these intermediates,
which it will then license to major firms
in the nylon value chain.
These three chemicals,
with a total market of over $18 billion per year,
are used primarily in the production of
nylon 6 and nylon 6,6,
also referred to as
the polyamides PA 6 and PA 6,6.
Christophe Schilling, Ph.D.,
CEO of Genomatica.
“Genomatica’s team, broad IP portfolio and
integrated biotechnology platform enable us
to develop processes for multiple high-volume chemicals,”
“Nylon intermediates are of high interest to us,
and a natural target for our R&D and
process engineering strengths.
We’re excited to formally unveil our nylon program.”
WWW.CHEMWINFO.COM BY KHUN PHICHAI
